657 filings
Page 9 of 33
8-K
c752s7agg2pcak1p7y71
14 Mar 19
Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update
4:14pm
EFFECT
zs117x
11 Feb 19
Notice of effectiveness
12:00am
UPLOAD
z4fmnwe8ccm2 h0
8 Feb 19
Letter from SEC
12:00am
CORRESP
eawd4pfm
7 Feb 19
Correspondence with SEC
12:00am
8-K
e5pejs v0p
22 Jan 19
Entry into a Material Definitive Agreement
4:25pm
EFFECT
pslfnbf uqt2kmdtnv0
10 Dec 18
Notice of effectiveness
12:16am
CORRESP
5622e0rp zq
4 Dec 18
Correspondence with SEC
12:00am
UPLOAD
8p19hi
4 Dec 18
Letter from SEC
12:00am
S-8
im5ombag
7 Nov 18
Registration of securities for employees
4:57pm
8-K
w28w7if4o3jr9bn5
7 Nov 18
Achieve Reports Financial Results for Third Quarter 2018 and Provides Cytisinicline (Cytisine) Clinical Development Update
12:00am
8-K
ekjp04iilifopd2
1 Oct 18
Achieve Announces Pricing of $5.6 Million Registered Direct Offering
5:11pm
424B5
fi2 m1jf7a9
1 Oct 18
Prospectus supplement for primary offering
5:04pm
8-K
0nhjahrb
28 Sep 18
Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability for a New Cytisine Formulation in Fed and Fasted Subjects
5:27pm
8-K
p536wo5qfmc7az
21 Sep 18
Submission of Matters to a Vote of Security Holders
4:05pm